Astal Laboratories Ltd — Important, 10-10-2025: Company Update

Astal Laboratories Limited's board approved acquiring 100% of Sriven Pharmachem India Private Limited (SPIPL), a drug intermediate and specialty chemicals manufacturer. This strategic move expands Astal's product range, aligning with its vision to be a fully integrated pharmaceutical company. The acquisition, valued at Rs. 277.17 crore, involves a 1:1 share swap, issuing over 3 crore new Astal shares. SPIPL's recent annual turnover was Rs. 102.70 crore, with a net profit of Rs. 0.70 crore. This aims to enhance operational strength and shareholder value, subject to shareholders' approval.